Heart Test Laboratories Stock Debt To Equity
| HSCS Stock | USD 4.28 0.32 8.08% |
Fundamental analysis of Heart Test allows traders to better anticipate movements in Heart Test's stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Debt To Equity | 0.13 | 0.12 |
Heart | Debt To Equity | Build AI portfolio with Heart Stock |
Heart Test Laboratories Company Debt To Equity Analysis
Heart Test's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Heart Test Debt To Equity | 0.41 % |
Most of Heart Test's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heart Test Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Heart Debt To Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Heart Test is extremely important. It helps to project a fair market value of Heart Stock properly, considering its historical fundamentals such as Debt To Equity. Since Heart Test's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heart Test's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heart Test's interrelated accounts and indicators.
Click cells to compare fundamentals
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
Heart Total Stockholder Equity
Total Stockholder Equity |
|
According to the company disclosure, Heart Test Laboratories has a Debt To Equity of 0.412%. This is 99.23% lower than that of the Health Care Equipment & Supplies sector and 98.97% lower than that of the Health Care industry. The debt to equity for all United States stocks is 99.15% higher than that of the company.
Heart Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heart Test's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heart Test could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics of similar companies.Heart Test is currently under evaluation in debt to equity category among its peers.
Heart Test ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Heart Test's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Heart Test's managers, analysts, and investors.Environmental | Governance | Social |
Heart Fundamentals
| Return On Equity | -1.63 | ||||
| Return On Asset | -0.63 | ||||
| Current Valuation | 5.02 M | ||||
| Shares Outstanding | 1.08 M | ||||
| Shares Owned By Insiders | 8.99 % | ||||
| Shares Owned By Institutions | 2.17 % | ||||
| Number Of Shares Shorted | 9.04 K | ||||
| Price To Book | 2.59 X | ||||
| Price To Sales | 202.07 X | ||||
| Revenue | 18.6 K | ||||
| EBITDA | (6.16 M) | ||||
| Net Income | (6.61 M) | ||||
| Cash And Equivalents | 4.27 M | ||||
| Cash Per Share | 0.52 X | ||||
| Total Debt | 1.04 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 3.53 X | ||||
| Book Value Per Share | 1.73 X | ||||
| Cash Flow From Operations | (6.07 M) | ||||
| Short Ratio | 0.62 X | ||||
| Earnings Per Share | (7.61) X | ||||
| Target Price | 13.0 | ||||
| Number Of Employees | 15 | ||||
| Beta | 2.63 | ||||
| Market Capitalization | 4.63 M | ||||
| Total Asset | 9.5 M | ||||
| Retained Earnings | (67.36 M) | ||||
| Working Capital | 5.6 M | ||||
| Net Asset | 9.5 M |
About Heart Test Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heart Test Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heart Test using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heart Test Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.